Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT02030600

Public ClinicalTrials.gov record NCT02030600. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 6:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted in the United States of America (USA). The aim of the trial is to compare the safety and efficacy of insulin degludec (IDeg) and insulin glargine (IGlar) with or without OADs (oral anti-diabetic drugs) excluding SUs (sulfonylureas)/glinides in subjects with type 2 diabetes.

Study identification

NCT ID
NCT02030600
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
721 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 6, 2014 (Actual)
Primary completion
Dec 4, 2015 (Actual)
Completion
Dec 4, 2015 (Actual)
Last update posted
May 10, 2019

2014 – 2015

United States locations

U.S. sites
161
U.S. states
36
U.S. cities
131
Facility City State ZIP Site status
Novo Nordisk Investigational Site Birmingham Alabama 35215-7502 —
Novo Nordisk Investigational Site Birmingham Alabama 35216 —
Novo Nordisk Investigational Site Haleyville Alabama 35565-1719 —
Novo Nordisk Investigational Site Montgomery Alabama 36106 —
Novo Nordisk Investigational Site Tuscumbia Alabama 35674 —
Novo Nordisk Investigational Site Chandler Arizona 85224 —
Novo Nordisk Investigational Site Phoenix Arizona 85050 —
Novo Nordisk Investigational Site Tucson Arizona 85704 —
Novo Nordisk Investigational Site Little Rock Arkansas 72205 —
Novo Nordisk Investigational Site Costa Mesa California 92626 —
Novo Nordisk Investigational Site Downey California 90242 —
Novo Nordisk Investigational Site El Cajon California 92020 —
Novo Nordisk Investigational Site Fresno California 93702 —
Novo Nordisk Investigational Site Fresno California 93720 —
Novo Nordisk Investigational Site Hawaiian Gardens California 90716 —
Novo Nordisk Investigational Site Huntington Park California 90255 —
Novo Nordisk Investigational Site Lincoln California 95648 —
Novo Nordisk Investigational Site Long Beach California 90807 —
Novo Nordisk Investigational Site Montclair California 91763 —
Novo Nordisk Investigational Site North Hollywood California 91606 —
Novo Nordisk Investigational Site Northridge California 91325 —
Novo Nordisk Investigational Site Pomona California 91766-2007 —
Novo Nordisk Investigational Site Poway California 92064 —
Novo Nordisk Investigational Site Rancho Cucamonga California 91730-3063 —
Novo Nordisk Investigational Site Rialto California 92376 —
Novo Nordisk Investigational Site Roseville California 95661 —
Novo Nordisk Investigational Site San Diego California 92111 —
Novo Nordisk Investigational Site Santa Monica California 90404 —
Novo Nordisk Investigational Site Tarzana California 91356-3551 —
Novo Nordisk Investigational Site Torrance California 90502 —
Novo Nordisk Investigational Site Tustin California 92780 —
Novo Nordisk Investigational Site Colorado Springs Colorado 80910 —
Novo Nordisk Investigational Site Golden Colorado 80401 —
Novo Nordisk Investigational Site Newark Delaware 19713 —
Novo Nordisk Investigational Site Bradenton Florida 34201 —
Novo Nordisk Investigational Site Chiefland Florida 32626 —
Novo Nordisk Investigational Site Clearwater Florida 33756 —
Novo Nordisk Investigational Site Clearwater Florida 33765 —
Novo Nordisk Investigational Site Cooper City Florida 33024 —
Novo Nordisk Investigational Site Doral Florida 33166 —
Novo Nordisk Investigational Site Hialeah Florida 33012 —
Novo Nordisk Investigational Site Hialeah Florida 33013 —
Novo Nordisk Investigational Site Jacksonville Florida 32204 —
Novo Nordisk Investigational Site Jacksonville Florida 32216 —
Novo Nordisk Investigational Site Jacksonville Florida 32256 —
Novo Nordisk Investigational Site Jacksonville Florida 32277 —
Novo Nordisk Investigational Site Miami Florida 33130 —
Novo Nordisk Investigational Site Miami Florida 33155 —
Novo Nordisk Investigational Site Miami Florida 33156 —
Novo Nordisk Investigational Site Miami Florida 33165 —
Novo Nordisk Investigational Site Miami Florida 33174 —
Novo Nordisk Investigational Site Miami Florida 33175 —
Novo Nordisk Investigational Site Miami Florida 33186 —
Novo Nordisk Investigational Site Miami Springs Florida 33166 —
Novo Nordisk Investigational Site Miramar Florida 33027 —
Novo Nordisk Investigational Site New Port Richey Florida 34652 —
Novo Nordisk Investigational Site Ocala Florida 34470 —
Novo Nordisk Investigational Site Orlando Florida 32801 —
Novo Nordisk Investigational Site Panama City Florida 32401 —
Novo Nordisk Investigational Site Pembroke Pines Florida 33026 —
Novo Nordisk Investigational Site Tampa Florida 33607 —
Novo Nordisk Investigational Site Tampa Florida 33619 —
Novo Nordisk Investigational Site Perry Georgia 31069 —
Novo Nordisk Investigational Site Champaign Illinois 61821 —
Novo Nordisk Investigational Site Chicago Illinois 60611 —
Novo Nordisk Investigational Site Evansville Indiana 47714 —
Novo Nordisk Investigational Site Muncie Indiana 47304 —
Novo Nordisk Investigational Site West Des Moines Iowa 50265 —
Novo Nordisk Investigational Site Lenexa Kansas 66219 —
Novo Nordisk Investigational Site Newton Kansas 67114 —
Novo Nordisk Investigational Site Lexington Kentucky 40502 —
Novo Nordisk Investigational Site Lexington Kentucky 40503 —
Novo Nordisk Investigational Site Louisville Kentucky 40213 —
Novo Nordisk Investigational Site Paducah Kentucky 42003 —
Novo Nordisk Investigational Site New Orleans Louisiana 70119 —
Novo Nordisk Investigational Site Shreveport Louisiana 71105 —
Novo Nordisk Investigational Site Brockton Massachusetts 02301 —
Novo Nordisk Investigational Site Kalamazoo Michigan 49009 —
Novo Nordisk Investigational Site Olive Branch Mississippi 38654-3573 —
Novo Nordisk Investigational Site Florissant Missouri 63031 —
Novo Nordisk Investigational Site Jefferson City Missouri 65109 —
Novo Nordisk Investigational Site Kansas City Missouri 64106 —
Novo Nordisk Investigational Site Henderson Nevada 89052-2649 —
Novo Nordisk Investigational Site Las Vegas Nevada 89148 —
Novo Nordisk Investigational Site Newington New Hampshire 03801 —
Novo Nordisk Investigational Site Morganville New Jersey 07751 —
Novo Nordisk Investigational Site Teaneck New Jersey 07666 —
Novo Nordisk Investigational Site Albuquerque New Mexico 87102 —
Novo Nordisk Investigational Site Albany New York 12208 —
Novo Nordisk Investigational Site Jackson Heights New York 11372 —
Novo Nordisk Investigational Site New Windsor New York 12553 —
Novo Nordisk Investigational Site Northport New York 11768 —
Novo Nordisk Investigational Site Smithtown New York 11787 —
Novo Nordisk Investigational Site Charlotte North Carolina 28277 —
Novo Nordisk Investigational Site Morganton North Carolina 28655 —
Novo Nordisk Investigational Site Winston-Salem North Carolina 27103 —
Novo Nordisk Investigational Site Delaware Ohio 43015 —
Novo Nordisk Investigational Site Franklin Ohio 45005 —
Novo Nordisk Investigational Site Toledo Ohio 43614 —
Novo Nordisk Investigational Site Oklahoma City Oklahoma 73103 —
Novo Nordisk Investigational Site Altoona Pennsylvania 16602 —
Novo Nordisk Investigational Site Beaver Pennsylvania 15009 —
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19107 —
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19114 —
Novo Nordisk Investigational Site Scottdale Pennsylvania 15683 —
Novo Nordisk Investigational Site Anderson South Carolina 29621 —
Novo Nordisk Investigational Site Gaffney South Carolina 29341 —
Novo Nordisk Investigational Site Greer South Carolina 29651 —
Novo Nordisk Investigational Site Pelzer South Carolina 29669 —
Novo Nordisk Investigational Site Spartanburg South Carolina 29303 —
Novo Nordisk Investigational Site Rapid City South Dakota 57701 —
Novo Nordisk Investigational Site Bristol Tennessee 37620-7352 —
Novo Nordisk Investigational Site Bristol Tennessee 37620 —
Novo Nordisk Investigational Site Chattanooga Tennessee 37404 —
Novo Nordisk Investigational Site Humboldt Tennessee 38343 —
Novo Nordisk Investigational Site Jackson Tennessee 38305 —
Novo Nordisk Investigational Site Johnson City Tennessee 37604 —
Novo Nordisk Investigational Site Kingsport Tennessee 37660 —
Novo Nordisk Investigational Site Arlington Texas 76012-4637 —
Novo Nordisk Investigational Site Arlington Texas 76012 —
Novo Nordisk Investigational Site Austin Texas 78758 —
Novo Nordisk Investigational Site Carrollton Texas 75007 —
Novo Nordisk Investigational Site Dallas Texas 75208 —
Novo Nordisk Investigational Site El Paso Texas 79912 —
Novo Nordisk Investigational Site Fort Worth Texas 76104 —
Novo Nordisk Investigational Site Houston Texas 77040 —
Novo Nordisk Investigational Site Houston Texas 77043 —
Novo Nordisk Investigational Site Houston Texas 77060 —
Novo Nordisk Investigational Site Houston Texas 77070 —
Novo Nordisk Investigational Site Houston Texas 77072 —
Novo Nordisk Investigational Site Houston Texas 77077 —
Novo Nordisk Investigational Site Humble Texas 77338 —
Novo Nordisk Investigational Site Hurst Texas 76054 —
Novo Nordisk Investigational Site Marshall Texas 75670 —
Novo Nordisk Investigational Site Mesquite Texas 75149 —
Novo Nordisk Investigational Site North Richland Hills Texas 76180 —
Novo Nordisk Investigational Site Plano Texas 75075 —
Novo Nordisk Investigational Site Plano Texas 75093 —
Novo Nordisk Investigational Site Richardson Texas 75080 —
Novo Nordisk Investigational Site San Antonio Texas 78215 —
Novo Nordisk Investigational Site San Antonio Texas 78224 —
Novo Nordisk Investigational Site San Antonio Texas 78228-3419 —
Novo Nordisk Investigational Site San Antonio Texas 78229 —
Novo Nordisk Investigational Site San Antonio Texas 78240 —
Novo Nordisk Investigational Site San Antonio Texas 78258 —
Novo Nordisk Investigational Site Sealy Texas 77474 —
Novo Nordisk Investigational Site Sugar Land Texas 77478 —
Novo Nordisk Investigational Site Sugar Land Texas 77479 —
Novo Nordisk Investigational Site Victoria Texas 77901 —
Novo Nordisk Investigational Site Waco Texas 76710 —
Novo Nordisk Investigational Site Draper Utah 84020 —
Novo Nordisk Investigational Site Ogden Utah 84405 —
Novo Nordisk Investigational Site Salt Lake City Utah 84107 —
Novo Nordisk Investigational Site Chesapeake Virginia 23321 —
Novo Nordisk Investigational Site Norfolk Virginia 23510 —
Novo Nordisk Investigational Site Olympia Washington 98502 —
Novo Nordisk Investigational Site Renton Washington 98057 —
Novo Nordisk Investigational Site Richland Washington 99352 —
Novo Nordisk Investigational Site Spokane Washington 99202-1334 —
Novo Nordisk Investigational Site Martinsburg West Virginia 25401 —
Novo Nordisk Investigational Site Kenosha Wisconsin 53144 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02030600, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 10, 2019 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02030600 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →